Company
Bermele plc
Headquarters: London, United Kingdom
Employees: 1
LSE: BERM
Bermele plc Categories
United Kingdom Healthcare BiotechnologyUnited Kingdom Healthcare United Kingdom Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Bermele plc does not have significant operations. It intends to acquire business or businesses operating in the pharmaceutical and biotechnology sectors. The company was incorporated in 2017 and is based in London, the United Kingdom.
Stocks & Indices
Bermele plc has the following listings and related stock indices.
Stock: LSE: BERM wb_incandescent